** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6

Public Alert No: 0022/2019 – Alert on Recall of Glosunate Plus 50 Tablets Batch Number GK18010 Due to Unsatisfactory Report of Laboratory Analysis

, The National Agency for Food and Drug Administration and Control (NAFDAC) has directed the Managing Director of Uche St. Company Limited to recall Glosunate Plus 50 (Artesunate 50mg and Amodiaquine 153mg) tablets Batch Number GK18010 manufactured by Globela Pharma Pvt, Gujarat, India up to retail level. Uche St. Company Ltd is the Marketing Authorization […]

Public Alert No: 0021/2019 – Alert on Recall of Solartep Tablets Batch Number F17S0826 Due to Unsatisfactory Report of Laboratory Analysis

, The National Agency for Food and Drug Administration and Control (NAFDAC) has directed the Managing Director of Solutions Pharmaceutical Nigeria Limited to recall Solartep (Dihydroartemisinin 40mg/Piperaquine Phosphate 320mg) tablets Batch Number F17S0826 manufactured by Mingshen Pharmaceutical Factory, China up to retail level. Solutions Pharmaceutical Limited is the Marketing Authorization Holder (MAH) of the product. […]